157 related articles for article (PubMed ID: 12939313)
21. C-peptide does not affect ocular blood flow in patients with type 1 diabetes.
Polska E; Kolodjaschna J; Berisha F; Malec MM; Simader C; Bayerle-Eder M; Roden M; Schmetterer L
Diabetes Care; 2006 Sep; 29(9):2034-8. PubMed ID: 16936149
[TBL] [Abstract][Full Text] [Related]
22. Role for nitric oxide in the hyperpermeability and hemodynamic changes induced by intravenous VEGF.
Tilton RG; Chang KC; LeJeune WS; Stephan CC; Brock TA; Williamson JR
Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):689-96. PubMed ID: 10067972
[TBL] [Abstract][Full Text] [Related]
23. Effects of acetazolamide on choroidal blood flow.
Dallinger S; Bobr B; Findl O; Eichler HG; Schmetterer L
Stroke; 1998 May; 29(5):997-1001. PubMed ID: 9596249
[TBL] [Abstract][Full Text] [Related]
24. Effect of histamine and cimetidine on retinal and choroidal blood flow in humans.
Resch H; Zawinka C; Lung S; Weigert G; Schmetterer L; Garhöfer G
Am J Physiol Regul Integr Comp Physiol; 2005 Nov; 289(5):R1387-91. PubMed ID: 16002558
[TBL] [Abstract][Full Text] [Related]
25. Intravenous administration of L-arginine increases retinal and choroidal blood flow.
Garhöfer G; Resch H; Lung S; Weigert G; Schmetterer L
Am J Ophthalmol; 2005 Jul; 140(1):69-76. PubMed ID: 15953576
[TBL] [Abstract][Full Text] [Related]
26. Nitric oxide modulation of ophthalmic artery blood flow velocity waveform morphology in healthy volunteers.
Lockhart CJ; Gamble AJ; Rea D; Hughes S; McGivern RC; Wolsley C; Stevenson M; Harbinson MT; Plumb RD; McVeigh GE
Clin Sci (Lond); 2006 Jul; 111(1):47-52. PubMed ID: 16499475
[TBL] [Abstract][Full Text] [Related]
27. Simultaneous measurement of ocular micro- and macrocirculation, intraocular pressure, and systemic functions.
Michelson G; Gründler A; Steinmeier R; Sigwanz U
Ger J Ophthalmol; 1994 Jan; 3(1):48-53. PubMed ID: 8142881
[TBL] [Abstract][Full Text] [Related]
28. Noninvasive investigations of the normal ocular circulation in humans.
Schmetterer L; Dallinger S; Findl O; Strenn K; Graselli U; Eichler HG; Wolzt M
Invest Ophthalmol Vis Sci; 1998 Jun; 39(7):1210-20. PubMed ID: 9620081
[TBL] [Abstract][Full Text] [Related]
29. Role of nitric oxide in maintenance of basal anterior choroidal blood flow in rats.
Koss MC
Invest Ophthalmol Vis Sci; 1998 Mar; 39(3):559-64. PubMed ID: 9501867
[TBL] [Abstract][Full Text] [Related]
30. The effects of sildenafil on ocular blood flow.
Koksal M; Ozdemir H; Kargi S; Yesilli C; Tomaç S; Mahmutyazicioglu K; Mungan A
Acta Ophthalmol Scand; 2005 Jun; 83(3):355-9. PubMed ID: 15948790
[TBL] [Abstract][Full Text] [Related]
31. Ocular hemodynamics during isometric exercise.
Kiss B; Dallinger S; Polak K; Findl O; Eichler HG; Schmetterer L
Microvasc Res; 2001 Jan; 61(1):1-13. PubMed ID: 11162191
[TBL] [Abstract][Full Text] [Related]
32. Effect of unspecific inhibition of cyclooxygenase by indomethacin on retinal and choroidal blood flow.
Weigert G; Berisha F; Resch H; Karl K; Schmetterer L; Garhofer G
Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1065-70. PubMed ID: 18326731
[TBL] [Abstract][Full Text] [Related]
33. A dose-response study of nitric oxide synthase inhibition in different vascular beds in man.
Hjorth Lassen L; Klingenberg Iversen H; Olesen J
Eur J Clin Pharmacol; 2003 Oct; 59(7):499-505. PubMed ID: 13680036
[TBL] [Abstract][Full Text] [Related]
34. Renal and ocular hemodynamic effects of insulin.
Schmetterer L; Müller M; Fasching P; Diepolder C; Gallenkamp A; Zanaschka G; Findl O; Strenn K; Mensik C; Tschernko E; Eichler HG; Wolzt M
Diabetes; 1997 Nov; 46(11):1868-74. PubMed ID: 9356038
[TBL] [Abstract][Full Text] [Related]
35. Vasodilator effects of L-arginine are stereospecific and augmented by insulin in humans.
Dallinger S; Sieder A; Strametz J; Bayerle-Eder M; Wolzt M; Schmetterer L
Am J Physiol Endocrinol Metab; 2003 Jun; 284(6):E1106-11. PubMed ID: 12736155
[TBL] [Abstract][Full Text] [Related]
36. A randomized, placebo-controlled, double-blind crossover study of the effect of pentoxifylline on ocular fundus pulsations.
Schmetterer L; Kemmler D; Breiteneder H; Alschinger C; Koppensteiner R; Lexer F; Fercher AF; Eichler HG; Wolzt M
Am J Ophthalmol; 1996 Feb; 121(2):169-76. PubMed ID: 8623886
[TBL] [Abstract][Full Text] [Related]
37. Effect of pituitary adenylate cyclase activating polypeptide 1-27 on ocular, cerebral and skin blood flow in humans.
Dorner GT; Wolzt M; Eichler HG; Schmetterer L
Naunyn Schmiedebergs Arch Pharmacol; 1998 Dec; 358(6):657-62. PubMed ID: 9879725
[TBL] [Abstract][Full Text] [Related]
38. Effect of oral felodipine on ocular circulation.
Schocket LS; Grunwald JE; Dupont J
Int Ophthalmol; 1999; 23(2):79-84. PubMed ID: 11196124
[TBL] [Abstract][Full Text] [Related]
39. Effect of systemic moxaverine on ocular blood flow in humans.
Resch H; Weigert G; Karl K; Pemp B; Garhofer G; Schmetterer L
Acta Ophthalmol; 2009 Nov; 87(7):731-5. PubMed ID: 18778333
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetic-pharmacodynamic profile of systemic nitric oxide-synthase inhibition with L-NMMA in humans.
Mayer BX; Mensik C; Krishnaswami S; Derendorf H; Eichler HG; Schmetterer L; Wolzt M
Br J Clin Pharmacol; 1999 May; 47(5):539-44. PubMed ID: 10336578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
